Studies

  1. A meta-analysis on the influence of inflammatory bowel disease on pregnancy

  2. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease

  3. Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  4. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease

  5. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

  6. Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort

  7. Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study

  8. Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease

  9. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

  10. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development